Pliant Therapeutics Presents Data From Phase 1 Trial Of PLN-101095 At AACR Annual Meeting 2026

Pliant Therapeutics, Inc. (NASDAQ: PLRX) announced that it will present data from its Phase 1 trial of PLN-101095 at the AACR Annual Meeting in San Diego from April 17-22, 2026. The trial's abstract has been selected for oral presentation during the Clinical Trials Mini Symposium.